Acne is not only a physical condition but also a significant psychosocial burden. Severe, treatment-resistant nodular acne can lead to scarring, emotional distress, and reduced self-esteem. Accufine 30 mg addresses these challenges by delivering a high daily dose of isotretinoin, a retinoid that targets all major pathogenic factors of acne: it shrinks sebaceous glands, reduces sebum production, normalizes follicular keratinization, and exerts potent anti-inflammatory effects.

By achieving higher systemic exposure early in treatment, the 30 mg regimen accelerates lesion resolution and promotes sustained remission. Rapid sebum reduction often becomes apparent within 2–4 weeks, improving dermatologic and psychological outcomes for patients living with severe, recalcitrant acne.

Off-label, Accufine 30 mg is also leveraged in refractory rosacea and hidradenitis suppurativa to harness its anti-inflammatory and keratinization-normalizing properties.

🧬 Pharmacology & Mechanism of Action

Isotretinoin modulates gene expression via retinoic acid receptors, leading to reduced sebocyte proliferation, normalized keratinization, and anti-inflammatory effects.

💡 Indications & Dosing

⚠️ Warnings & Side Effects

🏥 Storage Instructions

• Store at 20–25°C in original blister pack
• Protect from moisture and light
• Keep out of reach of children

🌐 Availability & Purchasing

• 🇺🇸 USA: Prescription-only (Accutane); isotretinoin under strict REMS.
• 🇬🇧 UK & EU: iPLEDGE equivalents require monitoring.
• 🇦🇺 Australia: Schedule 4 medicine; pregnancy prevention required.

Importing from India may reduce costs; ensure compliance with local guidelines and pregnancy prevention protocols.

🔗 Related Dermatologic Therapies